Get practical insights into modern bioanalytics and proven methods for biologics as well as cell & gene therapy development. In our live webinars, ProtaGene experts share real-world workflows, common pitfalls, and actionable takeaways — including live Q&A.
Effector functions such as CDC, ADCC, or ADCP play a critical role in the therapeutic efficacy of modern biologics, including monoclonal antibodies, bispecifics, ADCs, and Fc-engineered molecules. However, while binding assays confirm target interaction, they often provide limited insight into how these molecules engage and activate the immune system.
In this webinar, Christian Klein will show how advanced cell-based platforms enable deeper insights into immune activation and effector function. Reporter cell lines allow precise evaluation of receptor activation and downstream signaling, helping researchers better understand how molecular features such as Fc structure or glycosylation influence therapeutic performance.
Duration: approx. [45–60] minutes + live Q&A
Format: Live webinar (free)
Language: EN
Speaker: Dr. Christian Klein (ProtaGene)
Who should attend
Scientists in Biologics Development, Immunology, Bioassay Development, and Analytical Development
Teams looking to better understand and evaluate immune effector function using advanced cell-based assay platforms.
Deep-dive talks from leading experts in oncology and proteomics — available anytime.
Host cell proteins (HCPs) are process-related impurities that can impact product safety, efficacy, and stability. Mass spectrometry enables sensitive and comprehensive identification and characterization of HCPs, supporting effective risk assessment, process optimization, and regulatory compliance.
Watch Recording